Can Donald Trump singlehandedly withdraw the US from NATO?

President Trump said he is “absolutely” considering withdrawing the U.S. from NATO, but a 2023 law (enacted as part of the 2024 NDAA) requires Senate advice and consent — a two‑thirds vote — or an act of Congress. Practically, even with unanimous Republican support, at least 14 Democrats would need to join to pass withdrawal legislation, making unilateral exit unlikely and politically difficult. Legal experts note a potential court fight if the president attempted unilateral withdrawal: a 2020 DOJ opinion asserts executive treaty authority, but the statute would be violated and constitutional challenges by the White House are expected to be weak. Managers should monitor political rhetoric and legal developments for potential tail risks to defense and Europe‑exposed assets, though near‑term market disruption is unlikely.

Analysis

The immediate market effect will be a volatility spike, not a definitive structural break: legal and congressional frictions make an abrupt treaty exit low probability, but the executive has scope to degrade alliance functionality through funding, intelligence, and export-control levers. That asymmetric pathway creates concentrated operational risk for multinational defense supply chains (engines, guided munitions, C4ISR) where single-country political exposure magnifies delivery and FMS (foreign military sales) timing risk by 6–18 months.

Winners in the near-term are domestic U.S. primes and integrators that can be positioned as sovereign surrogates for risk-averse allies — think orders that are accelerated for interoperability, support, and surge logistics; expect 3–9 month order/backlog rephasing and margin tailwinds of 100–300bps on certain programs. Medium-term (12–36 months) beneficiaries are European/UK defense manufacturers if allies choose onshore procurement to reduce political dependence — that reallocation could redirect 10–30% of non-U.S. NATO procurement spend over a multi-year horizon.

Key catalysts and timelines: headline-driven equity moves (hours–weeks) around interviews and hearings; litigation/congressional fights (3–24 months) that determine binding constraints; and real-world escalation in the Gulf (days–months) that could force short-term surge buys. Reversals come from bipartisan Congressional discipline, senior military pushback, or rapid allied reassurance programs — any of which would collapse the headline premium within 48–72 hours.

For portfolio construction, treat this as a geopolitical convexity event — maintain small directional exposure to defense reallocation, buy short-dated downside protection for equities and FX, and prioritize names with low single-country export concentration and strong FMS backlog visibility. Position sizing should assume 20–35% headline-driven drawdowns with asymmetric upside over 6–24 months if procurement re-shoring accelerates.

Key Decisions for Investors

• Long Raytheon Technologies (RTX) 6–12 months: buy 2% NAV exposure via outright shares or buy the 9–12 month ITM call spread to capture order acceleration and higher services revenue. Target +20–30% upside if short-term FMS activity rises; stop-loss at -12%.
• Pair trade – Long BAE Systems ADR (BAESY) 12–24 months / Short Lockheed Martin (LMT) 12–24 months: size 1.5% NAV each leg to express a European procurement shift. Expect relative outperformance of BAESY vs LMT of 15–25% if allies move to onshore buys; horizon 12–36 months. Risk: geopolitical normalization could reverse within weeks.
• Short-term hedge: Buy 1–3 week TLT or GLD exposure (or put spreads on S&P) sized to offset 5–10% equity VaR around major hearings or Gulf escalation. This protects portfolio during 48–72 hour headline spikes where equities typically gap down 2–6%.
• FX hedge: Buy USD via UUP or sell EURUSD with a 1–3 month horizon sized to cover dollardenominated NAV risk — a modest 0.5–1% NAV position expecting USD strength on geopolitical flight-to-safety. Take profits if EURUSD < 1.03 or after clear bipartisan reassurance.